Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 18-Nov-24
Select bar for recommendation details.
Recommendations | 18-Nov-24 | |
---|---|---|
Buy | 2 | |
Outperform | 1 | |
Hold | 4 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 6 analysts offering 12 month price targets for Amylyx Pharmaceuticals Inc have a median target of 7.50, with a high estimate of 12.00 and a low estimate of 3.00. The median estimate represents a 44.51% increase from the last price of 5.19.
High | 131.2% | 12.00 |
Med | 44.5% | 7.50 |
Low | -42.2% | 3.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Feb 20, 2025.
Average growth rate | -12.60% |
Average growth rate | +74.61% |
More ▼
Revenue history & estimates in USD
Average growth rate | -6.33% |
Average growth rate | +4,656.47% |
More ▼